Baidu
map
COMMUN BIOL 润色咨询

Communications Biology

出版年份：暂无数据 年文章数：3101 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2024-07-10 ms2000000117316111 来自广西

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享：Editor Review Started 3rd Jul 24
    Initial Manuscript Review Started 21st Jun 24
    Editor Assigned 19th Jun 24
    Submission 14th Jun 24
    Manuscript Transferred 14th Jun 24

    已经过去快一个月啦
    7号收到的送审邮件
    更新攒人品

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2024-07-24 ms8000000795739494 来自江苏省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向：骨发育;蛋白酶;软骨内成骨
    经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2024-06-20 ms2000000208112241 来自辽宁省

    6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2024-05-11 流离岁月 来自浙江省

    请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。
    Review #2 received
    Review #    1 received
    Reviewer #2 agreed
    Reviewer #    1 agreed
    5 reviewer(s) invited
    Invitations sent on 13 Mar, 2024

    12

    展开12条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2024-06-12 xyzt 来自广东省

    投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2023-12-14 ms3000001957865221 来自湖北省

    decision made好几天了都没有更新状态，是被拒了吗

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2024-03-26 ms7000000088062990 来自北京

    偏重的研究方向：眼科;角膜
    经验分享：第一次尝试。
    更新攒人品拉！
    Initial Manuscript Review Started 26th Mar 24
    Editor Assigned 25th Mar 24
    Submission 20th Mar 24
    希望可以顺利

    10

    展开10条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2024-02-07 sunyong_97 来自江苏省

    Editor Review Started已经两天了，External Editor还是Not Assigned。

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2024-06-03 ms7000000214967727 来自福建省

    偏重的研究方向：基因组学
    经验分享：6月1日提交，submission状态，希望好运！！！

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：Editor Review Started 3rd Jul 24<br>Initial Manuscript Review Started 21st Jun 24<br>Editor Assigned 19th Jun 24<br>Submission 14th Jun 24<br>Manuscript Transferred 14th Jun 24<br><br>已经过去快一个月啦<br>7号收到的送审邮件<br>更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：骨发育;蛋白酶;软骨内成骨<br>经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤生物学<br>经验分享：经验分享，第一轮<br>Stage Start Date<br>Revision Received 31st Jan 24<br>Waiting for Revision 31st Jan 24<br>Decision Made 30th Jan 24<br>Editor Review Started 13th Jan 24<br>Initial Manuscript Review Started 8th Jan 24<br>Editor Assigned 8th Jan 24<br>Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]
    2024-01-31 ms1000000620292943 来自福建省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向：肿瘤生物学
    经验分享：经验分享，第一轮
    Stage Start Date
    Revision Received 31st Jan 24
    Waiting for Revision 31st Jan 24
    Decision Made 30th Jan 24
    Editor Review Started 13th Jan 24
    Initial Manuscript Review Started 8th Jan 24
    Editor Assigned 8th Jan 24
    Submission 28th Dec 23

    4

    展开4条回复
共218条页码: 1/22页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map